The Pharmacist’s Role Amid Measles Surge, Vaccine Policy Change

On August 10, 2026, President Donald Trump signed an executive order titled “Delivering Gold Standard Childhood Vaccine Recommendations for Americans,” directing federal agencies to split combination childhood vaccines into single shots given at separate visits.¹

This order comes amidst a major surge in measles cases across the US, with confirmed infections rising to 2465 by early August and reaching 3231 by early September. Major medical organizations and public health experts have strongly criticized the directive, warning that separating combination shots is unproven, costly, and hazardous to pediatric health.^1-3

In a special rendition of the Over the Counter podcast, we welcomed a trio of public health, infectious disease, and pediatrics experts to discuss the ongoing measles phenomenon.

Drug Topics was joined by Thomas Lew, MD, ABIM, assistant clinical professor of medicine at the Stanford University School of Medicine; Molly O’Shea, MD, FAAP, practicing pediatrician and owner of Birmingham Pediatrics & Wellness Center in Bloomfield Hills, Michigan; and Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending physician of infectious diseases at Georgetown University.

Starting with Lew, we tapped into his expertise to understand pharmacist-patient relationships amid these outbreaks. Then, we discussed the pediatrician’s perspective with O’Shea and ended on Goodman’s insights regarding the policy angle of this ongoing public health issue.

READ MORE: How Pharmacists Can Address Measles Misinformation with Patients

The Dangers of Ongoing Outbreaks and Declining Vaccine Rates

The ongoing spike in measles infections highlights a troubling drop in national immunization coverage, as kindergarten MMR rates fell to 92.5%, well below the 95% threshold needed to prevent community transmission. National tracking data reveals that most cases stem from local community transmission rather than international travel, with school-aged children heavily impacted.^1,2

In certain counties, vaccination rates have fallen much lower, eroding herd immunity and allowing rapid viral spread in local communities. Health professionals emphasize that measles is highly contagious and can lead to severe complications, including pneumonia, brain inflammation, immune amnesia, and death.²

Containing measles outbreaks imposes heavy financial and operational burdens on health care systems. Public health data indicates that managing a single measles case costs approximately $60,000 due to intensive contact tracing, isolation protocols, and specialized care.

Outbreak responses force clinics and hospitals to divert limited resources away from routine appointments, pediatric wellness visits, and chronic care. Splitting the MMR vaccine into 3 separate doses would multiply system strains by requiring 4 extra medical visits per child, adding billions of dollars in health care expenses.

How Pharmacists Can Step In

As accessible health care providers in nearly every US neighborhood, pharmacists serve as trusted sources for families seeking reliable health information. The executive order’s recommendation to offer single-disease shots cannot be implemented immediately because no standalone measles, mumps, or rubella vaccines are currently licensed or produced in the US.¹

Consequently, the order’s primary immediate impact is creating confusion and doubt among parents. Pharmacists are now on the front lines, carrying increased responsibility to address patient questions and reinforce confidence in routine immunizations.

Medical leaders stress that despite executive announcements, the established childhood immunization schedule supported by the American Academy of Pediatrics (AAP) remains in effect. When addressing hesitant parents, pharmacists and pediatricians recommend using supportive communication methods rather than direct myth-busting, which can make patients and their parents defensive.³

Asking open-ended questions, validating concerns, and seeking permission to share clinical evidence helps build trust. Pharmacists can assure parents that the combined MMR vaccine provides strong protection without overloading a child’s immune system.

READ MORE: Declining MMR Rates Rely on Collaboration for Path Forward

Additionally, infectious disease experts like Goodman confirm that there is no clinical rationale for separating the MMR vaccine into individual injections. Uncoupling combination vaccines leaves children vulnerable to preventable infections during the intervals between separate appointments.

By staying grounded in scientific literature and maintaining open dialogue, community pharmacists play a vital role in protecting public health during this ongoing surge.

Stay tuned for weekly podcast episodes of Over the Counter powered by Drug Topics. Check out our most recent episode with Scott Stoll and Kenzie Hohman, PharmD, who discussed the importance of pharmacy advocacy in driving the profession forward on a national and local scale.

REFERENCES

1. Borio L, Krause P. New U.S. vaccine order creates confusion amid measles surge. Think Global Health. August 14, 2026. Accessed September 9, 2026. https://www.thinkglobalhealth.org/article/new-u-s-vaccine-order-creates-confusion-amid-measles-surge

2. Tracking measles cases in the U.S. Johns Hopkins Bloomberg School of Public Health. September 4, 20206. Accessed September 9, 2026. https://publichealth.jhu.edu/ivac/resources/us-measles-tracker

3. Brown C. Why Trump’s order to split MMR vaccine is costly and dangerous. BMJ. 2026;394:e100632. doi:10.1136/bmj-2026-100632.